These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7843758)

  • 21. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension.
    Higashi Y; Oshima T; Sasaki S; Nakano Y; Kambe M; Matsuura H; Kajiyama G
    Hypertension; 1998 Jul; 32(1):16-24. PubMed ID: 9674632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.
    Iñigo P; Campistol JM; Lario S; Piera C; Campos B; Bescós M; Oppenheimer F; Rivera F
    J Am Soc Nephrol; 2001 Apr; 12(4):822-827. PubMed ID: 11274244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year follow-up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients.
    Beltman F; Heesen W; Smit A; May J; de Graeff P; Havinga T; Schuurman F; van der Veur E; Lie K; Meyboom-de Jong B
    J Hypertens Suppl; 1998 Oct; 16(6):S15-9. PubMed ID: 9856379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients.
    Chanard J; Toupance O; Lavaud S; Hurault de Ligny B; Bernaud C; Moulin B
    Nephrol Dial Transplant; 2003 Oct; 18(10):2147-53. PubMed ID: 13679494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
    Hasler C; Nussberger J; Maillard M; Forclaz A; Brunner HR; Burnier M
    Clin Pharmacol Ther; 2005 Nov; 78(5):501-7. PubMed ID: 16321616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P; Cody RJ; Sealey JE; Laragh JH
    Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats.
    Karam H; Clozel JP; Bruneval P; Gonzalez MF; Ménard J
    Hypertension; 1999 Oct; 34(4 Pt 1):673-8. PubMed ID: 10523345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome].
    Shevchenko OP; Praskurnichiĭ EA; Savel'eva SA
    Ter Arkh; 2008; 80(4):54-9. PubMed ID: 18491582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H; Sayiner ZA; Kilisli H
    Clin Exp Hypertens; 2012; 34(2):145-52. PubMed ID: 21967026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial.
    Midtvedt K; Hartmann A; Holdaas H; Fauchald P
    Clin Transplant; 2001 Dec; 15(6):426-31. PubMed ID: 11737121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic angiotensin-converting enzyme inhibition may improve sodium excretion in cardiac transplant hypertension.
    Schwietzer GK; Hartmann A; Kober G; Jungmann E; Stratmann D; Kaltenbach M; Schoeppe W
    Transplantation; 1995 Apr; 59(7):999-1004. PubMed ID: 7709462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
    Statsenko ME; Derevianchenko MV
    Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
    Wu SC; Liu CP; Chiang HT; Lin SL
    Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy.
    Holdaas H; Hartmann A; Berg KJ; Lund K; Fauchald P
    Nephrol Dial Transplant; 1998 Dec; 13(12):3096-102. PubMed ID: 9870472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.